Results 201 to 210 of about 231,766 (309)

Bloodstream Infection in an Immunocompromised Host After Unusual Presentation of Photo Recall Dermatitis. [PDF]

Am J Case Rep
Immel S, Ahmed J, Castelo-Soccio L, Powers JH.   +3 more
europepmc   +1 more source

Recurrence Rates of Incompletely Excised Primary Basal Cell Carcinoma Treated With Mohs Micrographic Surgery and Radiotherapy

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives Incompletely excised primary basal cell carcinoma (pBCC) is a frequently encountered scenario in clinical practice, yet the significance of the phenomenon is not well described in current literature. Re‐excision is recommended for high‐risk incompletely excised pBCCs, but recurrence rates post re‐excision of pBCCs with ...
Georgia De'Ambrosis, Brian De'Ambrosis, Perry Wilson, Alexander Coe   +3 more
wiley   +1 more source

Immunocompromised Status Definition in Observational Studies Using Electronic Health Records: A Scoping Review and a Proposal for a Phenotype Identification Algorithm. [PDF]

Pharmacoepidemiol Drug Saf
Riera-Arnau J, Luxi N, Riefolo F, Solorzano M, Pazos I, Ballarín E, Svingel LS, Chiusaroli L, Martín-Merino E, Barbieri E, Lopez-Lasanta M, Mohammadi S, Rotta D, Pacurariu A, Cohet C, Sturkenboom M, Durán CE, SAFETY‐VAC study consortium.   +17 more
europepmc   +1 more source

Type I and II Interferons Drive Abacavir Hypersensitivity via Treg Suppression and T‐Cell Enhancement in Immunocompetent HLA‐Transgenic Mice

Allergy, EarlyView.
Upregulated HLA‐B*57:01 expression in Tg/KO mice amplifies abacavir‐specific CD8+ T‐cell activation, driven by enhanced antigen presentation. Abacavir treatment induces robust pDC expansion and IFN‐α production, which selectively suppresses memory Treg populations.
SuJin Hwang, Telly Sepahpour, Stephanie Kortchak, Kirthiram Krishnaveni Sivakumar, Spyros Karaiskos, Ngoc Pham, Yura Jang, Montserrat Puig, Michael Norcross   +8 more
wiley   +1 more source

Review of Infections in Immunocompromised Travellers: Epidemiology, Infection Prevention and Management. [PDF]

Microorganisms
Duduveche AE, Mohorea-Neata AL, Badelita SN.   +2 more
europepmc   +1 more source

Mesenchymal Stem Cells From a Klinefelter Syndrome Patient: Functional Characterization and Therapeutic Implications

Andrology, EarlyView.
ABSTRACT Background Cell therapy, particularly those utilizing mesenchymal stem/stromal cells (MSCs), is gaining traction as a therapeutic option for regenerative treatment in patients with limited therapeutic options. Although the safety of MSC‐based interventions is well established, uncertainties remain regarding how genetic abnormalities and ...
Marzena Zychowicz, Wioletta Lech, Anna Figiel‐Dabrowska, Marta Kot, Magdalena Murzyn, Natalia Malawska, Barbara Pienkowska‐Grela, Zuzanna Sandowska‐Markiewicz, Iwona Ziolkowska‐Suchanek, Agnieszka Zimna, Tomasz Oldak, Natalia Rozwadowska, Anna Sarnowska   +12 more
wiley   +1 more source

Correction. [PDF]

Hum Vaccin Immunother
europepmc   +1 more source

Real-world effectiveness of remdesivir in immunocompromised patients hospitalized due to SARS-CoV-2 Infection: Insights to inform pharmacy practice. [PDF]

Am J Health Syst Pharm
Kalil AC, Chima-Melton C, Naslazi E, Ramroth H, Amin AN, Pettit NN, Gottlieb RL.   +6 more
europepmc   +1 more source

Changing Aetiology of Perforated Peptic Ulcers: Rising Impact of Non‐Steroidal‐Anti‐Inflammatories in Western Australia

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background Peptic ulcer disease (PUD) continues to be a health issue, mainly due to Helicobacter pylori (H. pylori) infection and non‐steroidal anti‐inflammatory drugs (NSAIDs). Despite better treatment of H. pylori and use of proton pump inhibitors, the rate of reduction in PUD complications is slowing down.
Vidya Willis, Tamalee Wilson, David R. Fletcher, Amanda J. Foster   +3 more
wiley   +1 more source